Pheochromocytoma-Induced Hyperglycemia Leading To Misdiagnosis Of Type 1 Diabetes Mellitus
Author(s) -
D G Bole,
Barbara Simón
Publication year - 2016
Publication title -
aace clinical case reports
Language(s) - English
Resource type - Journals
ISSN - 2376-0605
DOI - 10.4158/ep161210.cr
Subject(s) - medicine , pheochromocytoma , metanephrine , normetanephrine , adrenalectomy , hypoglycemia , diabetes mellitus , multiple endocrine neoplasia , perioperative , insulin , type 2 diabetes mellitus , endocrinology , blood pressure , acromegaly , type 2 diabetes , urology , surgery , hormone , growth hormone , biochemistry , chemistry , gene
Objective: We describe a young patient who had hyperglycemia as a sign of pheochromocytoma. He had been diagnosed with type 1 diabetes, but insulin was ultimately discontinued. We also examine the impact of metyrosine on glucose levels during the perioperative period of adrenalectomy. Methods: We present a case report with clinical, imaging, and laboratory findings and provide a brief review of the literature. Results: A 31-year-old man presented with uncontrolled hypertension. His urinary metanephrine levels were very high (metanephrine 51,460 μg/24 hours; normetanephrine 17,666 μg/24 hours). Magnetic resonance imaging revealed bilateral enlarged adrenal glands (left 6.5 × 6.0 × 5.7 cm; right 8.3 × 8.4 × 7.9 cm) and he was diagnosed with pheochromocytoma. In preparation for bilateral adrenalectomy, his blood pressure was controlled with phenoxybenzamine and metyrosine. Glucose levels and exogenous insulin declined with metyrosine therapy. The patient was determined to have multiple endocrine neo...
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom